| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | May 14, 2024 | Option Exercise | $2.48 | 1,107 | 2,745 | 1,107 | May 16, 2024, 07:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | May 14, 2024 | Sale | $25.00 | 1,107 | 27,675 | 0 | May 16, 2024, 07:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | May 09, 2024 | Option Exercise | $2.48 | 260 | 645 | 260 | May 13, 2024, 07:35 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | May 09, 2024 | Sale | $25.06 | 260 | 6,515 | 0 | May 13, 2024, 07:35 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | May 06, 2024 | Option Exercise | $2.48 | 4,875 | 12,090 | 4,875 | May 08, 2024, 08:40 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | May 06, 2024 | Sale | $22.72 | 4,875 | 110,769 | 0 | May 08, 2024, 08:40 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | Apr 11, 2024 | Option Exercise | $2.48 | 14,903 | 36,959 | 17,500 | Apr 15, 2024, 07:06 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | Apr 11, 2024 | Sale | $25.03 | 17,500 | 438,099 | 0 | Apr 15, 2024, 07:06 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | Apr 08, 2024 | Sale | $18.60 | 4,875 | 90,687 | 3,141 | Apr 10, 2024, 08:35 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | Mar 06, 2024 | Sale | $15.64 | 4,875 | 76,239 | 7,472 | Mar 08, 2024, 07:52 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | CHIEF OPERATING OFFICER | Feb 06, 2024 | Sale | $15.11 | 4,875 | 73,658 | 12,347 | Feb 08, 2024, 08:47 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | Chief Operating Officer | Jan 22, 2024 | Sale | $15.14 | 4,875 | 73,783 | 17,222 | Jan 24, 2024, 06:38 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | Chief Operating Officer | Dec 28, 2023 | Sale | $15.08 | 2,520 | 37,996 | 33,117 | Jan 02, 2024, 08:00 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | Chief Operating Officer | Dec 29, 2023 | Sale | $15.00 | 20 | 300 | 33,097 | Jan 02, 2024, 08:00 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | Chief Operating Officer | Jan 02, 2024 | Sale | $15.00 | 11,000 | 165,053 | 22,097 | Jan 02, 2024, 08:00 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | Chief Operating Officer | Dec 22, 2023 | Sale | $15.03 | 983 | 14,776 | 35,739 | Dec 27, 2023, 05:28 PM | |
| ELVN | Enliven Therapeutics, Inc. | Patel Anish | Chief Operating Officer | Dec 26, 2023 | Sale | $15.01 | 102 | 1,531 | 35,637 | Dec 27, 2023, 05:28 PM |
Menu